Research Reports

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) Analyst Report: Positive FDA Catalyst Has Emerging Biopharmaceutical Player Back In the Clinical Trial Business

OXBT Research Report Written by Michael Andereg,

Chartered Financial Analyst

Experienced investment professional specializing in financial markets research with significant technical and fundamental competencies.  Comprehensive analytical framework incorporates time cycle and multi-timeframe trend analysis to cover a wide variety of instruments and market conditions.

Published April 21, 2014

Use the PDF Icon provided below to get the full report on OXBT.